G9800 Beta-Blocker Intolerance HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS G9800: Beta-Blocker Intolerance or Allergy

HCPCS Level II code G9800 documents patients identified as having an intolerance or allergy to beta-blocker therapy. Nationally, recording such contraindications is important for medication safety, clinical decision support, and care coordination across ambulatory and specialty settings. Accurate use of the code helps ensure appropriate alternative therapies, avoids medication errors, and informs prior authorization and formulary decisions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical context for using HCPCS Level II code G9800, the typical sites of service where it is applied, and how payers commonly consider documented beta-blocker intolerance when managing coverage and care pathways. The publication also summarizes common modifiers and related administrative considerations when this code appears on claims.

The report provides practical benchmarks and policy context relevant to clinicians, billing professionals, and payer policy teams. It highlights documentation requirements, implications for medication management, and intersections with utilization management processes. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9800HCPCS Level IIbeta-blocker intolerancemedication allergyambulatory carebilling guidanceclinical documentation

Billing Code Overview

HCPCS Level II code G9800 identifies patients who are intolerant of or allergic to beta-blocker therapy. This designation documents that beta-blockers are contraindicated for the patient due to adverse reactions or documented intolerance.

Service type: Medication therapy assessment and documentation of medication intolerance/allergy
Typical site of service: Outpatient clinics, primary care offices, cardiology practices, and other ambulatory care settings where medication histories and therapy decisions are made

Clinical & Coding Specifications

Clinical Context

A 68-year-old patient with a history of ischemic heart disease and chronic obstructive pulmonary disease (COPD) presents to a cardiology clinic for medication management after a recent acute coronary syndrome. The cardiologist determines that beta-blocker therapy is contraindicated due to a documented severe bronchospastic reaction and records an allergy/intolerance to beta-blockers in the chart. The clinic documents the intolerance to support therapy decisions, coordinate care with primary care, and communicate with the patient’s pharmacy and payor for alternative treatment coverage. Typical workflow: review of past medical history and medication reactions, verification of the beta-blocker intolerance in the electronic health record (EHR), counseling on alternative agents (e.g., nondihydropyridine calcium channel blockers or selective agents if appropriate), documentation of the intolerance with G9800 on the patient’s problem list and in visit billing records, and communication to the pharmacy and referring clinicians. Typical site of service is outpatient clinic or ambulatory cardiology practice; may also appear in home health or skilled nursing facility documentation when medication intolerance affects ongoing management.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when additional documentation supports substantially greater complexity of office or evaluation time related to management because of the documented beta-blocker intolerance.

HCPCS G2081: Institutional SNP or Long-Term Care Residence >90 Days

HCPCS-G9731-PATIENT-UNABLE-TO-COMPLETE-LEPF-PROM

HCPCS G9731: Patient Unable to Complete LEPF PROM

HCPCS-G2075-MEDICATION-ASSISTED-TREATMENT-WEEKLY-BUNDLE-OTP

HCPCS G2075: Medication Assisted Treatment Weekly Bundle

HCPCS-G9960-DOCUMENTATION-SYSTEMIC-ANTIMICROBIAL-REASON

HCPCS G9960: Documentation of Medical Reason for Systemic Antimicrobials

HCPCS-G6042-AMPHETAMINE-METHAMPHETAMINE-TESTING

HCPCS G6042: Amphetamine or Methamphetamine Testing

HCPCS-G9746-MITRAL-STENOSIS-PROSTHETIC-VALVE-TRANSIENT-AF

HCPCS G9746: AF with Mitral Stenosis, Prosthetic Valve, or Reversible Cause

HCPCS-G8634-NOT-ELIGIBLE-FOR-PHARMACOLOGIC-OSTEOPOROSIS-THERAPY

HCPCS G8634: Clinician-documented Not Eligible for Osteoporosis Pharmacologic Therapy

HCPCS-G9712-ANTIBIOTIC-MEDICAL-JUSTIFICATION-DOCUMENTATION

HCPCS G9712: Documentation of Medical Reason for Antibiotic Prescribing

HCPCS-G9427-ED-PAIN-MEDICATION-TIMELINESS-MEASURE

HCPCS G9427: ED Timeliness for Initial Pain Medication

HCPCS-G8734-ELDER-MALTREATMENT-SCREEN-NEGATIVE-NO-FOLLOW-UP

HCPCS G8734: Elder Maltreatment Screen Documented Negative, No Follow-Up Required

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207RC0000X`	Cardiology	Cardiology providers document intolerance when selecting alternative cardiac medications.
`207RH0000X`	Internal Medicine	Internists commonly manage chronic disease and document medication allergies/intolerances.
`363A00000X`	Nurse Practitioner	NPs in ambulatory cardiology or primary care assess and document intolerance and coordinate care.
`363L00000X`	Physician Assistant	PAs in cardiology or primary care frequently document and manage medication intolerances.
`207L00000X`	Pulmonology	Pulmonologists evaluate bronchospastic reactions and provide input when beta-blocker intolerance affects respiratory status.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J44.1`	Chronic obstructive pulmonary disease with (acute) exacerbation	COPD with bronchospasm is a common clinical reason to avoid nonselective beta-blockers due to risk of bronchoconstriction.
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	A common cardiac condition where beta-blocker intolerance impacts secondary prevention and symptom management.
`I21.9`	Acute myocardial infarction, unspecified	Acute coronary syndromes often prompt consideration of beta-blockers; intolerance alters acute and chronic management.
`I50.9`	Heart failure, unspecified	Heart failure management frequently includes beta-blockers; intolerance necessitates alternative therapies and close monitoring.
`T88.1XXA`	Other complications of medical or surgical care, initial encounter (allergic reaction)	Used to document a documented adverse reaction/intolerance to beta-blocker therapy when an allergic-type reaction occurred.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for follow-up visits where beta-blocker intolerance is reviewed and medication changes are made.
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, typically 25 minutes	Used when the visit requires moderate complexity decision making due to comorbidities and management alternatives to beta-blockers.
`99406`	Smoking and tobacco use cessation counseling, intermediate, greater than 3 minutes up to 10 minutes	May be relevant when counseling on risk reduction that influences choices of alternate therapies in patients with respiratory intolerance.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Performed to assess cardiac status when selecting alternatives to beta-blockers.
`93228`	External mobile cardiovascular telemetry with electrocardiographic real-time data analysis and greater than 48 hours, up to 30 days	Used when extended rhythm monitoring is needed as part of medication changes because beta-blocker therapy cannot be used.
`99495`	Transitional care management, moderate medical decision complexity (face-to-face within 14 days)	Used when care transitions require medication reconciliation and documentation of beta-blocker intolerance affecting post-discharge management.

OpenPayer